Immunogenicity evaluation of ChAdox1 nCov-19 (AZD1222) vaccine in solid cancer patients in Chulabhorn Hospital

• Auteurs principaux: Piyarat Limpawittayakul (Auteur), Prakongboon Sungkasubun (Auteur), Worawit Chaiwiriyawong (Auteur), Archara Supavavej (Auteur), Bowon Weerasubpong (Auteur), Jomtana Siripaibun (Auteur), Chumut Phanthunane (Auteur), Wisut Lamlertthon (Auteur), Teerapat Ungtrakul (Auteur), Kriangkrai Tawinprai (Auteur), Walaipan Tantiyavarong (Auteur), Chayanee Samdaengpan (Auteur)
• Format: Livre
• Publié: Taylor & Francis Group, 2022-11-01T00:00:00Z.
• Sujets: article
• Accès en ligne: Connect to this object online.

Introduction Cancer patients are more vulnerable to coronavirus disease 2019 (COVID-19) owing to their compromised immune status. However, data regarding COVID-19 vaccine safety and immune response in cancer patients are scarce. Method This prospective, age- and sex-matched, single-center cohort stu...